Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis

FASEB Journal

Volumn 24, Issue 6, 2010, Pages 1997-2009

  Mader, Isabelle ^a   Wabitsch, Martin ^a   Debatin, Klaus Michael ^a   Fischer Posovszky, Pamela ^a   Fulda, Simone ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cell death; Death receptor; Preadipocytes

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CYTOCHROME C; FAS ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADIPOCYTE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROADIPOCYTE; RNA INTERFERENCE; SENSITIZATION; SUBCUTANEOUS FAT; WHITE ADIPOSE TISSUE;

ADIPOCYTES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASES; CELLS, CULTURED; CYTOCHROMES C; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEINS; HUMANS; IMMUNOPRECIPITATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIRTUIN 1; STILBENES; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77953521260     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-142943     Document Type: Article

References (64)

1. Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., and Eckel, R. H. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler. Thromb. Vasc. Biol. 26, 968-976
2. Greenberg, A. S., and Obin, M. S. (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr. 83, 461S-465S
3. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, A. W., Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808
4. Warne, J. P. (2003) Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J. Endocrinol. 177, 351-355
5. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., and Chen, H. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830
6. Falschlehner, C., Schaefer, U., and Walczak, H. (2009) Following TRAIL's path in the immune system. Immunology 127, 145-154
7. Koubova, J., and Guarente, L. (2003) How does calorie restriction work? Genes Dev. 17, 313-321
8. Bluher, M., Kahn, B. B., and Kahn, C. R. (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299, 572-574
9. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M. W., and Guarente, L. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771-776
10. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L. L., Scherer, B., and Sinclair, D. A. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196
11. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., and Sinclair, D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689
12. Haigis, M. C., and Guarente, L. P. (2006) Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913-2921
13. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., Pistell, P. J., Poosala, S., Becker, K. G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K. W., Spencer, R. G., Lakatta, E. G., Le Couteur, D., Shaw, R. J., Navas, P., Puigserver, P., Ingram, D. K., de Cabo, R., and Sinclair, D. A. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342
14. Baur, J. A., and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506
15. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell 127, 1109-1122
16. Fulda, S., and Debatin, K. M. (2006) Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect. Prev. 30, 217-223
17. Fischer-Posovszky, P., Wabitsch, M., and Hochberg, Z. (2007) Endocrinology of adipose tissue-an update. Horm. Metab. Res. 39, 314-321
18. Prins, J. B., and O'Rahilly, S. (1997) Regulation of adipose cell number in man. Clin. Sci. (Lond.) 92, 3-11
19. Sorisky, A., Magun, R., and Gagnon, A. M. (2000) Adipose cell apoptosis: death in the energy depot. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 4), S3-S7
20. Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Naslund, E., Britton, T., Concha, H., Hassan, M., Ryden, M., Frisen, J., and Arner, P. (2008) Dynamics of fat cell turnover in humans. Nature 453, 783-787
21. Lockshin, R. A., and Zakeri, Z. (2007) Cell death in health and disease. J. Cell. Mol. Med. 11, 1214-1224
22. Fulda, S., and Debatin, K. M. (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798-4811
23. Ashkenazi, A. (2008) Targeting the extrinsic apoptosis pathway in cancer. Cytokine Growth Factor Rev. 19, 325-331
24. Kroemer, G., Galluzzi, L., and Brenner, C. (2007) Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87, 99-163 (Pubitemid 46209992)
25. Fischer-Posovszky, P., Tornqvist, H., Debatin, K. M., and Wabitsch, M. (2004) Inhibition of death-receptor mediated apoptosis in human adipocytes by the insulin-like growth factor I (IGF-I)/IGF-I receptor autocrine circuit. Endocrinology 145, 1849-1859
26. Rayalam, S., Yang, J. Y., Ambati, S., Della-Fera, M. A., and Baile, C. A. (2008) Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother. Res. 22, 1367-1371
27. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Ambati, S., Hartzell, D. L., Park, H. J., and Baile, C. A. (2008) Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82, 1032-1039
28. Rayalam, S., Della-Fera, M. A., Yang, J. Y., Park, H. J., Ambati, S., and Baile, C. A. (2007) Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J. Nutr. 137, 2668-2673
29. Park, H. J., Yang, J. Y., Ambati, S., Della-Fera, M. A., Hausman, D. B., Rayalam, S., and Baile, C. A. (2008) Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J. Med. Food 11, 773-783
30. Bai, L., Pang, W. J., Yang, Y. J., and Yang, G. S. (2008) Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol. Cell. Biochem. 307, 129-140
31. Szkudelska, K., Nogowski, L., and Szkudelski, T. (2009) The inhibitory effect of resveratrol on leptin secretion from rat adipocytes. Eur J. Clin. Invest.
32. Szkudelska, K., Nogowski, L., and Szkudelski, T. (2009) Resveratrol, a naturally occurring diphenolic compound, affects lipogenesis, lipolysis and the antilipolytic action of insulin in isolated rat adipocytes. J. Steroid. Biochem. Mol. Biol. 113, 17-24
33. Backesjo, C. M., Li, Y., Lindgren, U., and Haldosen, L. A. (2009) Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. Cells Tissues Organs 189, 93-97
34. Floyd, Z. E., Wang, Z. Q., Kilroy, G., and Cefalu, W. T. (2008) Modulation of peroxisome proliferator-activated receptor gamma stability and transcriptional activity in adipocytes by resveratrol. Metabolism 57, S32-38
35. Gonzales, A. M., and Orlando, R. A. (2008) Curcumin and resveratrol inhibit nuclear factor-B-mediated cytokine expression in adipocytes. Nutr. Metab. (Lond.) 5, 17
36. Fulda, S., and Debatin, K. M. (2004) Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 64, 337-346
37. Fulda, S., and Debatin, K. M. (2004) Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23, 6702-6711
38. Fulda, S., and Debatin, K.-M. (2005) Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. Eur. J. Cancer 41, 786-798
39. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (Pubitemid 19196649)
40. Wabitsch, M., Brenner, R. E., Melzner, I., Braun, M., Moller, P., Heinze, E., Debatin, K. M., and Hauner, H. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. Relat. Metab. Disord. 25, 8-15
41. Wabitsch, M., Heinze, E., Debatin, K. M., and Blum, W. F. (2000) IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm. Metab. Res. 32, 555-559 (Pubitemid 32176086)
42. Fulda, S., Friesen, C., Los, M., Scaffidi, C., Mier, W., Benedict, M., Nunez, G., Krammer, P. H., Peter, M. E., and Debatin, K. M. (1997) Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57, 4956-4964 (Pubitemid 27469008)
43. La Ferla-Bruhl, K., Westhoff, M. A., Karl, S., Kasperczyk, H., Zwacka, R. M., Debatin, K. M., and Fulda, S. (2007) NF-κB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene 26, 571-582
44. Opel, D., Westhoff, M. A., Bender, A., Braun, V., Debatin, K. M., and Fulda, S. (2008) Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res. 68, 6271-6280
45. Häcker, S., Dittrich, A., Mohr, A., Schweitzer, T., Rutkowski, S., Krauss, J., Debatin, K. M., and Fulda, S. (2009) Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. Oncogene 28, 3097-3110
46. Vogler, M., Walczak, H., Stadel, D., Haas, T. L., Genze, F., Jovanovic, M., Gschwend, J. E., Simmet, T., Debatin, K. M., and Fulda, S. (2008) Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Cancer Res. 68, 7956-7965
47. Chou, T. C. (1991) The median-effect principle and the combination index for quantitation of synergism and antagonism. In Synergism and Antagonism in Chemotherapy (Chou, T. C., ed) pp. 61-102, Academic Press, San Diego, CA, USA
48. Guicciardi, M. E., and Gores, G. J. (2009) Life and death by death receptors. FASEB J. 23, 1625-1637
49. Kohlhaas, S. L., Craxton, A., Sun, X. M., Pinkoski, M. J., and Cohen, G. M. (2007) Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. J. Biol. Chem. 282, 12831-12841
50. Altieri, D. C. (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat. Rev. Cancer 8, 61-70
51. Parcellier, A., Tintignac, L. A., Zhuravleva, E., and Hemmings, B. A. (2008) PKB and the mitochondria: AKTing on apoptosis. Cell. Signal. 20, 21-30
52. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R., and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
53. Delmas, D., Rebe, C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., and Solary, E. (2004) Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 23, 8979-8986
54. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., and Solary, E. (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J. Biol. Chem. 278, 41482-41490
55. Ivanov, V. N., Partridge, M. A., Johnson, G. E., Huang, S. X., Zhou, H., and Hei, T. K. (2008) Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp. Cell. Res. 314, 1163-1176
56. Gill, C., Walsh, S. E., Morrissey, C., Fitzpatrick, J. M., and Watson, R. W. G. (2007) Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67, 1641-1653
57. Shankar, S., Chen, Q., Siddiqui, I., Sarva, K., and Srivastava, R. K. (2007) Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4′, 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential. J. Mol. Signal. 2, 7
58. Shankar, S., Siddiqui, I., and Srivastava, R. K. (2007) Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol. Cell. Biochem. 304, 273-285
59. Hambrock, A., de Oliveira Franz, C. B., Hiller, S., Grenz, A., Ackermann, S., Schulze, D. U., Drews, G., and Osswald, H. (2007) Resveratrol binds to the sulfonylurea receptor (SUR) and induces apoptosis in a SUR subtype-specific manner. J. Biol. Chem. 282, 3347-3356
60. Lin, H. Y., Lansing, L., Merillon, J. M., Davis, F. B., Tang, H. Y., Shih, A., Vitrac, X., Krisa, S., Keating, T., Cao, H. J., Bergh, J., Quackenbush, S., and Davis, P. J. (2006) Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J. 20, 1742-1744
61. Gross, K., Karagiannides, I., Thomou, T., Koon, H. W., Bowe, C., Kim, H., Giorgadze, N., Tchkonia, T., Pirtskhalava, T., Kirkland, J. L., and Pothoulakis, C. (2009) Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1012-G1019
62. Choi, J. W., Song, J. S., and Pai, S. H. (2004) Associations of serum TRAIL concentrations, anthropometric variables, and serum lipid parameters in healthy adults. Ann. Clin. Lab. Sci. 34, 400-404
63. Boocock, D. J., Faust, G. E., Patel, K. R., Schinas, A. M., Brown, V. A., Ducharme, M. P., Booth, T. D., Crowell, J. A., Perloff, M., Gescher, A. J., Steward, W. P., and Brenner, D. E. (2007) Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol. Biomarkers. Prev. 16, 1246-1252
64. Alcain, F. J., and Villalba, J. M. (2009) Sirtuin activators. Expert Opin. Ther. Pat. 19, 403-414